Different phases of clinical trials that are run to develop a new test or treatment, such as a drug. Phase I (one) involves using healthy human volunteers to check the safety of the test or treatment. In phases II–IV (two to four), patients with the disease that the researchers are interested in are given the treatment and the optimal dose is worked out. Researchers study these patients to see whether it works, how long the effects last and whether there are any adverse effects. HTAI
Recently Added
- So You Want to Build Your Disease’s First Online Patient Registry: An Educational Guide
- Involve Australia – Guidelines for Community Involvement in Genomic Research
- Holiday Gift Guide 2023
- Interacting with Patient Communities: Areas for Pharmaceutical companies to consider
- PVI CaPPRE Enhancing Patient Engagement in Australia Report 2023